ArticleNaunyn-Schmiedeberg's archives of pharmacology2025
Geraniol modulates inflammatory and antioxidant pathways to mitigate intestinal ischemia-reperfusion injury in male rats.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Geraniol and Z-guggulsterone co-treatment attenuates Alzheimer's disease in adult zebrafish by targeting oxidative damage, neuroinflammation, mitochondrial stress, and synaptic dysfunction.Inflammopharmacology · 2026Article
- Geraniol alleviates DNCB-induced atopic dermatitis in mice by downregulating IL-4/IL-13 and reducing inflammation.Biomolecules & biomedicine · 2026Article
- Antibacterial Activity of Palmarosa (Pharmaceutics · 2025Article
- Polyherbal Therapeutics Mitigate CClReproductive sciences (Thousand Oaks, Calif.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intestinal ischemia-reperfusion injury (IIR/I) significantly increases morbidity and mortality. This study examines the therapeutic effects of geraniol (GNL), which is noted for its anti-inflammatory and antioxidant properties, on intestinal I/R injury in rats. Forty-nine male Wistar-Albino rats were divided into seven groups. After 30 min of ischemia and subsequent reperfusion for either 1 or 6 h, intestinal and hepatic tissues were analyzed. Biochemical assessments measured malondialdehyde (MDA), glutathione peroxidase (GPx), superoxide dismutase (SOD), catalase (CAT), myeloperoxidase (MPO), and nitric oxide (NO) activities. Inflammatory and apoptotic markers were evaluated using qRT-PCR and ELISA, and apoptotic cell rates were determined by flow cytometry. GNL treatment significantly protected intestinal and hepatic tissues, enhancing antioxidant enzyme activity and normalizing MDA and NO activities. It demonstrated notable anti-inflammatory effects at 100 and 200 mg/kg doses, reducing TNF-α, IL-1β, and IL-6 levels while decreasing tissue MPO content. GNL also increased Bcl-2 levels and decreased Bax levels, indicating anti-apoptotic effects. Serum activities of ALT, AST, and creatine kinase were lower in GNL-treated rats, and flow cytometry showed a reduction in apoptotic cells. GNL effectively mitigated oxidative stress and histopathological damage from intestinal I/R injury by reducing pro-apoptotic markers and increasing anti-apoptotic markers, highlighting its protective effects.
Indexed as
Identifiers
39841219What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.